KCT0008430尚未招募Unknown
A multicenter randomized prospective study of heparin wet-suction versus conventional suction for EUS-FNB of solid pancreatic mass
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 174
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1. Men and women aged 20 or older who voluntarily obtained consent (In the case of elderly subjects, read and sign the signed consent form after fully explaining the research content verbally before reading the written consent form, and if possible, listen to the explanation together.)
- •2. Patients who agree to the clinical trial
- •3. Pancreatic solid mass
- •4. Size of lesion: =1 cm in long diameter
排除标准
- •1. Pregnant women
- •2. Blood clotting disorder (PLT<50,000/mm3, INR>1.5 sec)
- •3. Patients who have difficulty performing ultrasound endoscopy due to cardiopulmonary dysfunction
- •4. Cystic main lesion
- •5. Patients who disagree with the clinical study
- •6. Patients who cannot access biopsy under ultrasound endoscopy (e.g., anatomical deformation due to intervening blood vessels, gastrectomy, etc.)
- •7. Patients under 20 years of age
研究者
相似试验
进行中（未招募）
不适用
A clinical study to evaluate HF10 therapy using surgical leadsISRCTN10619673evro Corp339
已完成
不适用
A multicenter prospective cohort study on hepatocarcinogenesis in patients with chronic hepatitis C after sustained virological response to direct acting antiviralsChronic hepatitis C after sustained virological responseJPRN-UMIN000016982Saga Study Group of Liver Diseases300
已完成
不适用
A prospective multicenter cohort study in patients with pancreatic cysts less than 10 mm in sizePancreatic cysts less than 10 mm in sizeJPRN-UMIN000023213Japan Pancreas Society1,131
进行中（未招募）
1 期
Exploring the efficacy and safety of rivaroxaban to support elective percutaneous coronary intervention.Symptomatic CAD patients due to undergo an elective (non emergent) Percutaneous Coronary Intervention (PCI) on one or two lesions in the native coronary vessel(s).MedDRA version: 13.1Level: PTClassification code 10011078Term: Coronary artery diseaseSystem Organ Class: 10007541 - Cardiac disordersEUCTR2011-001094-58-BEBayer HealthCare AG105
进行中（未招募）
不适用
Exploring the efficacy and safety of rivaroxaban to support elective percutaneous coronary intervention.EUCTR2011-001094-58-NLBayer HealthCare AG105